Cellectis S.A

Home » Cellectis S.A

Secondary

Cellectis S.A

We are a clinical stage biotechnological company, employing our core proprietary technologies to develop best-in-class products in the field of immuno-oncology.

Symbol

CLLS

Last Closing Price
$30.73

Shares
4,600,000

Anticipated Date
TBD

Underwriters
Goldman Sachs, Citigroup, Barclays

To view the prospectus for Cellectis S.A, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253